Cellectis S.A. CLLS

$ 3.87 3.75%

Annual report 2025
added 04-25-2026

Cellectis S.A. DIO Ratio 2011-2026 | CLLS

Annual DIO Ratio Cellectis S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	23.3	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
23.3	23.3	23.3

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Biohaven Pharmaceutical Holding Company Ltd. BHVN	239	$ 9.32	1.19 %	$ 603 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Aptorum Group Limited APM	4.89	$ 0.89	0.51 %	$ 6.54 M	China
	ACADIA Pharmaceuticals ACAD	295	$ 22.48	1.26 %	$ 3.73 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Aquestive Therapeutics AQST	120	$ 4.08	0.74 %	$ 436 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 22.96	2.64 %	$ 2.92 B	USA
	Edesa Biotech EDSA	184	$ 15.11	-4.97 %	$ 48.3 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.44	1.77 %	$ 383 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Exelixis EXEL	96.1	$ 45.14	1.01 %	$ 12.3 B	USA